Home
About
Overview
Sharing Data
ORCID
Help
History (8)
Mouse Sbp2 deficiency models the multi-system syndrome of human SBP2 defects
Optimization of Metabolic Tumor Volume as a Prognostic Marker in CAR T-Cell Therapy for Aggressive Large B-cell NHL.
Principal Investigator
Chaperone Assisted Crystallography
Low-Strength Type I Interferon Signaling Promotes CAR T-Cell Treatment Efficacy.
See All 8 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Low-Strength Type I Interferon Signaling Promotes CAR T-Cell Treatment Efficacy.
Low-Strength Type I Interferon Signaling Promotes CAR T-Cell Treatment Efficacy. bioRxiv. 2025 May 20.
View in:
PubMed
authors with profiles
Justin Kline
Peter Riedell
James LaBelle
Michael Bishop